The title of Areva on the Paris Stock Exchange. The French nuclear giant has announced it will miss one of its 2014 targets and has frozen its financial outlook for the next two years. The shares lost 18,49%, to 9,83 euros, when the Cac40 slipped by 0,18%.
The share, which is at its lowest since June 2012, has been under pressure for a few months now and has lost about half of its value since 20 January this year. Last August 2014, in particular, he left XNUMX% on the ground after indicating a reduction in the targets for XNUMX.
Yesterday Areva made it known that it had given up on achieving one of its main objectives for the current year, namely cash flow close to equilibrium. As regards 2015 and 2016, the estimates are suspended pending their revision, which will be carried out before the publication of the 2014 financial statements, scheduled for 25 February 2015.
